Weight-loss injections have become a trend, sparked a frenzy and attracted a level of publicity few medicines have ever enjoyed. Yet while the debate largely focuses on adults using them to lose weight, there is another, far less publicised reality. Injectable treatments for obesity can now, under specific medical conditions, be prescribed even to children from the age of 12.
How did we get here? The answer lies not only in advances in pharmacology. It also lies in the spread of childhood obesity, which Dr Nicolas Nicolaides describes as a pandemic, while also sounding the alarm over the emergence of type 2 diabetes from adolescence onwards.
Speaking on Politis' podcast Without a Gown, the University of Cyprus assistant professor of paediatrics and specialist in paediatric endocrinology confirms that these treatments can be an option during adolescence. He stresses, however, that a simple prescription is not enough. Clear medical indications are required, along with a named-patient application to the Health Insurance Organisation explaining why the specific treatment has been chosen for a child. The request is then subject to an approval process.
That does not mean the drugs are an appropriate solution for every child who is overweight.
According to Nicolaides, studies conducted so far have produced encouraging results in terms of both effectiveness and safety. He points to improvements in body mass index and waist circumference, while acknowledging side effects, primarily involving the gastrointestinal system.
Asked what is known about the long-term impact on children who may require treatment for years, he refers to the evidence emerging from studies and meta-analyses to date.
These drugs, he notes, are not a magic solution. They act on the mechanisms of hunger and satiety, but they do not replace healthy eating, exercise and adequate sleep.
The diabetes affecting teenagers
The need for such interventions is linked to a reality that the doctor describes with concern.
Type 2 diabetes, once seen mainly in adults, is now appearing with increasing frequency even among adolescents, particularly after the age of 12.
Obesity raises the risk because it is associated with insulin resistance and increased demands on the pancreas. That does not mean, he makes clear, that every child with obesity will develop diabetes.
What concerns him most is the path these children may follow into adulthood.
A teenager with type 2 diabetes may already require medication, while the disease's long-term complications can affect the eyes, kidneys and nerves. The better blood sugar is controlled, the lower the risk of developing those complications.
Society in the frame
Nicolaides insists that obesity is a disease with multiple contributing factors, including genetic predisposition.
It is therefore not enough simply to tell children what they should eat.
He describes parents working long hours, children moving from school to private lessons, and free time increasingly spent in front of screens rather than playing outdoors.
He also refers to the Cypriot grandmother who shows her affection through biscuits and chocolates, without blaming her or advocating a ban on sweets.
He acknowledges that school canteens require closer monitoring, while noting that the contents of a pupil's lunch bag are also determined at home.
He warns against a second pitfall: efforts to tackle obesity should not demonise foods or foster a hostile relationship with food.
Particularly during adolescence, he notes, there is a risk of eating disorders.
Prevention, he explains, does not necessarily begin at school. New scientific approaches are examining factors that go as far back as parental health before conception.


